• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非冻结性冷伤的早期使用依前列醇。

Early Use of Iloprost in Nonfreezing Cold Injury.

机构信息

Royal Cornwall Hospitals NHS Trust, United Kingdom.

Royal Cornwall Hospitals NHS Trust, United Kingdom.

出版信息

Wilderness Environ Med. 2022 Sep;33(3):344-347. doi: 10.1016/j.wem.2022.04.009. Epub 2022 Jul 12.

DOI:10.1016/j.wem.2022.04.009
PMID:35840449
Abstract

Nonfreezing cold injury (NFCI) is caused by prolonged exposure to cold, usually wet conditions and represents a separate pathological entity from frostbite. The pathophysiology of NFCI is characterized by vasoconstriction and microcirculatory disturbance. Iloprost, a synthetic prostaglandin analogue with vasodilatory properties is a recognized adjuvant treatment in frostbite; however, its role in NFCI is unclear. We present a case of a 29-y-old man with severe NFCI to both forefeet after prolonged immersion in cold seawater. Initial treatment with passive rewarming, analgesia and aspirin was initiated. Infusion of iloprost was used within 24 h from presentation and was well tolerated. This resulted in reduced tissue loss compared to the apparent tissue damage documented during the initial assessment. Delayed surgical intervention allowed minor debridement and minor toe amputations, maintaining the patient's ability to ambulate. This case demonstrates the safe use of iloprost in acute NFCI and highlights the importance of delayed surgical intervention in patients presenting with severe NFCI.

摘要

非冻结性冷伤(NFCI)是由长时间暴露于寒冷、通常是潮湿的环境中引起的,与冻伤是不同的病理实体。NFCI 的病理生理学特征是血管收缩和微循环障碍。前列地尔是一种具有血管扩张作用的合成前列腺素类似物,已被确认为冻伤的辅助治疗药物;然而,其在 NFCI 中的作用尚不清楚。我们报告了一例 29 岁男性,因长时间浸泡在冷海水中,双脚前足严重冻伤。最初采用被动复温、镇痛和阿司匹林进行治疗。在发病后 24 小时内使用前列地尔输注,患者耐受性良好。与初始评估期间记录的明显组织损伤相比,这导致组织损失减少。延迟手术干预允许进行小面积清创和小趾截肢,保持了患者的步行能力。该病例证明了在急性 NFCI 中使用前列地尔是安全的,并强调了在严重 NFCI 患者中延迟手术干预的重要性。

相似文献

1
Early Use of Iloprost in Nonfreezing Cold Injury.非冻结性冷伤的早期使用依前列醇。
Wilderness Environ Med. 2022 Sep;33(3):344-347. doi: 10.1016/j.wem.2022.04.009. Epub 2022 Jul 12.
2
Can iloprost be used for treatment of cold weather injury at the point of wounding in a forward operating environment? A literature review.伊洛前列素可否用于野战环境下创伤部位的冷天伤治疗?文献综述。
Int J Circumpolar Health. 2023 Dec;82(1):2210340. doi: 10.1080/22423982.2023.2210340.
3
Nonfreezing Cold Injury (Trench Foot).非冻结性冷伤(战壕足)。
Int J Environ Res Public Health. 2021 Oct 6;18(19):10482. doi: 10.3390/ijerph181910482.
4
Potential new treatment for non-freezing cold injury: is Iloprost the way forward?非冻伤性冷损伤的潜在新疗法:伊洛前列素是前进的方向吗?
J R Army Med Corps. 2017 Oct;163(5):361-363. doi: 10.1136/jramc-2016-000672. Epub 2017 Mar 23.
5
The peripheral vascular responses in non-freezing cold injury and matched controls.非冻结性冷伤与匹配对照的周围血管反应。
Exp Physiol. 2023 Mar;108(3):420-437. doi: 10.1113/EP090721. Epub 2023 Feb 19.
6
Iloprost for the treatment of frostbite: a scoping review.依前列醇治疗冻伤:范围综述。
Int J Circumpolar Health. 2023 Dec;82(1):2189552. doi: 10.1080/22423982.2023.2189552.
7
Nonfreezing Cold Injury and Cold Intolerance in Paddlesport.桨板运动中的非冻结性冷伤和冷不耐受
Wilderness Environ Med. 2022 Jun;33(2):187-196. doi: 10.1016/j.wem.2022.03.003. Epub 2022 Apr 29.
8
Case Report: Severe Frostbite in Extreme Altitude Climbers-The Kathmandu Iloprost Experience.病例报告:极端海拔高度登山者的严重冻伤——加德满都伊洛前列素治疗经验
Wilderness Environ Med. 2018 Sep;29(3):366-374. doi: 10.1016/j.wem.2018.03.003. Epub 2018 Jun 8.
9
Nonfreezing Cold Injuries Among Long-Distance Polar Rowers.长途极地划船者中的非冻伤性冷损伤
Wilderness Environ Med. 2020 Jun;31(2):209-214. doi: 10.1016/j.wem.2019.12.009. Epub 2020 Apr 16.
10
Case series of non-freezing cold injury: the modern clinical syndrome.非冻结性冷伤病例系列:现代临床综合征。
BMJ Mil Health. 2020 Oct;166(5):324-329. doi: 10.1136/jramc-2018-001099. Epub 2019 Mar 2.